Search

Li Xiao

from Newark, DE
Age ~39
Get Report
Also known as:
Xiao Li
Related to:
Linda L Gilbert, 62Donghui Li, 50Sheng B Dong, 49Jie Ji, 34Chinling L Wang, 65Jia Li, 62Hao Wang, 36Xiao LiHaofan Wang, 55Feng Lin, 52Ji JiehuaBoyan LiFeng LiLihua Hua Wang, 53
Connected to:
Alex M Xiao, 29Anne Xiao, 28Annie Xiao, 32Baohua Xiao, 54Carol W Xiao, 54Ching Xiao, 75Chunfang Xiao, 46Cong Y Xiao, 38Connie Xiao, 28Daniel B Xiao, 33

Li Xiao Phones & Addresses

  • Newark, DE
  • Ballwin, MO
  • Fresh Meadows, NY

Work

Company: Bank of america - Wilmington, DE Oct 2011 Position: Short sale dil specialist

Education

School / High School: LeBow College of Business, Drexel University- Philadelphia, PA 2009 Specialities: Master of Business Administration in Finance and Marketing

Skills

Effective verbal and written communicati... • investment analysts • accountants • consultants • clients • and others. Good at teamwork. Strong qua...

Specialities

Buyer's Agent • Listing Agent

Resumes

Resumes

Li Xiao Photo 1

Research Assistant

View page
Location:
Philadelphia, PA
Industry:
Higher Education
Work:
University of Delaware
Research Assistant
Education:
Nankai University 2009 - 2012
Master of Science, Masters, Statistics Wuhan University 2007 - 2009
Bachelors, Finance Wuhan University 2005 - 2009
Bachelors, Bachelor of Science, Mathematics
Skills:
Statistics
Li Xiao Photo 2

Li Xiao

View page
Li Xiao Photo 3

Li Xiao

View page
Li Xiao Photo 4

Li Xiao

View page
Li Xiao Photo 5

Li Xiao

View page
Li Xiao Photo 6

Li Xiao

View page
Li Xiao Photo 7

Li Xiao

View page
Li Xiao Photo 8

Li Xiao Redwood City, CA

View page
Work:
Bank of America
Wilmington, DE
Oct 2011 to Feb 2012
Short sale DIL Specialist
The Spruce Foundation
Philadelphia, PA
Jan 2011 to Jun 2011
Marketing Intern
Abington Memorial Health Center
Willow Grove, PA
Apr 2009 to Jan 2010
PC Analyst
Xinken Corp

Sep 1998 to Mar 2001
Sales Representative and Sales Manager
Education:
LeBow College of Business, Drexel University
Philadelphia, PA
2009 to 2011
Master of Business Administration in Finance and Marketing
Lakeland College
Madison, WI
2004 to 2006
B.S. in Accounting
Shihezi University
1994 to 1998
B.S. in Plant Science
Skills:
Effective verbal and written communications with colleagues, investment analysts, accountants, consultants, clients, and others. Good at teamwork. Strong quantitative and analytical skills.

Business Records

Name / Title
Company / Classification
Phones & Addresses
Li Ping Xiao
YINGLU INTERNATIONAL APPAREL CORP
C/O Zhuangmu Liu Cpa Pllc 136-81 Roosevelt Ave, Flushing, NY 11354
Li Qin Xiao
President
GENERAL MONGOLIAN INC
Eating Place
1 E Broadway FL 3, New York, NY 10038
903 Bitter Rd SUITE 310, San Antonio, TX 78216
903 E Bitters Rd, San Antonio, TX 78216

Publications

Us Patents

Novel Substituted Piperazine Amide Compounds As Indoleamine 2,3-Dioxygenase (Ido) Inhibitors

View page
US Patent:
20230008022, Jan 12, 2023
Filed:
Nov 25, 2019
Appl. No.:
17/295497
Inventors:
Dane CLAUSEN - Kenilworth NJ, US
Ping CHEN - Kenilworth NJ, US
Xavier FRADERA - Boston MA, US
Liangqin GUO - Kenilworth NJ, US
Yongxin HAN - Boston MA, US
Shuwen HE - Fanwood NJ, US
Xianhai HUANG - Warren NJ, US
Joseph KOZLOWSKI - Princeton NJ, US
Guoqing LI - Kenilworth NJ, US
Theodore A. MARTINOT - Southborough MA, US
Alexander PASTERNAK - Boston MA, US
Andreas VERRAS - New York NY, US
Li XIAO - Kenilworth NJ, US
Wensheng YU - Kenilworth NJ, US
Rui ZHANG - Kenilworth NJ, US
- Rahway NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
C07D 231/56
C07D 491/052
C07D 231/54
A61K 31/496
C07D 401/12
C07D 401/14
C07D 413/12
A61K 31/5377
C07D 498/10
C07D 491/107
C07D 498/08
C07D 471/10
C07D 403/12
C07D 405/12
C07D 498/04
C07D 487/04
C07D 487/10
A61K 31/541
C07D 413/14
Abstract:
Disclosed herein are compounds of formula (I) which are inhibitors of an IDO enzyme: (I). Also disclosed herein are uses of the compounds in the potential treatment or prevention of an IDO-associated disease or disorder. Also disclosed herein are compositions comprising these compounds. Further disclosed herein are uses of the compositions in the potential treatment or prevention of an IDO-associated disease or disorder.

Novel Substituted Pyrazole Compounds As Indoleamine 2,3-Dioxygenase Inhibitors

View page
US Patent:
20210395240, Dec 23, 2021
Filed:
Oct 28, 2019
Appl. No.:
17/287256
Inventors:
Dane CLAUSEN - Kenilworth NJ, US
- Rahway NJ, US
Liangqin Guo - Monroe Township NJ, US
Yongxin Han - Needham MA, US
Shuwen He - Fanwood NJ, US
Joseph Kozlowski - Princeton NJ, US
Guoqing Li - Belle Mead NJ, US
Theodore A. Martinot - Southborough MA, US
Alexander Pasternak - Jamaica Plain MA, US
David Sloman - Newton MA, US
Li Xiao - Cranbury NJ, US
Wensheng Yu - Edison NJ, US
Rui Zhang - Plainsboro NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
C07D 413/14
C07D 401/14
Abstract:
Disclosed herein are compounds of formula (I) which are inhibitors of an IDO enzyme: (I). Also disclosed herein are uses of the compounds in the potential treatment or prevention of an IDO-associated disease or disorder. Also disclosed herein are compositions comprising these compounds. Further disclosed herein are uses of the compositions in the potential treatment or prevention of an IDO-associated disease or disorder.

Metallo-Beta-Lactamase Inhibitors And Methods Of Use Thereof

View page
US Patent:
20200375987, Dec 3, 2020
Filed:
Dec 20, 2018
Appl. No.:
16/769670
Inventors:
Alexander PASTERNAK - Kenilworth NJ, US
Shuzhi DONG - Kenilworth NJ, US
Jack D. SCOTT - Kenilworth NJ, US
Haiqun TANG - Kenilworth NJ, US
Zhiqiang ZHAO - Kenilworth NJ, US
Dexi YANG - Kenilworth NJ, US
Li XIAO - Kenilworth NJ, US
Xin GU - Scotch Plains NJ, US
- Rahway NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 31/4985
C07D 487/04
C07D 471/04
A61K 31/4439
A61K 31/519
A61K 31/4188
C07D 513/04
C07D 403/10
A61K 31/4178
A61K 31/407
A61K 31/496
A61K 31/165
A61K 31/7048
A61K 31/546
A61P 31/04
Abstract:
The present invention relates to metallo-β-lactamase inhibitor compounds of Formula I: and pharmaceutically acceptable salts thereof, wherein R, R, and Z are as defined herein. The present invention also relates to compositions which comprise a metallo-β-lactamase inhibitor compound of the invention or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, optionally in combination with a beta lactam antibiotic and/or a beta-lactamase inhibitor. The invention further relates to methods for treating a bacterial infection comprising administering to a patient a therapeutically effective amount of a compound of the invention, in combination with a therapeutically effective amount of one or more β-lactam antibiotics and optionally in combination with one or more beta-lactamase inhibitor compounds. The compounds of the invention are useful in the methods described herein for overcoming antibiotic resistance.
Control profile
Li Xiao from Newark, DE, age ~39 Get Report